MAMs and Mitochondrial Quality Control: Overview and Their Role in Alzheimer's Disease
Jian-Sheng Luo1, Wen-Hu Zhai1, Ling-Ling Ding2
1Department of Anesthesiology, Deyang People's Hospital, Deyang, 618000, China.
Abstract:
Alzheimer's disease (AD) represents the most widespread neurodegenerative disorder, distinguished by a gradual onset and slow progression, presenting a substantial challenge to global public health. The mitochondrial-associated membrane (MAMs) functions as a crucial center for signal transduction and material transport between mitochondria and the endoplasmic reticulum, playing a pivotal role in various pathological mechanisms of AD. The dysregulation of mitochondrial quality control systems is considered a fundamental factor in the development of AD, leading to mitochondrial dysfunction and subsequent neurodegenerative events. Recent studies have emphasized the role of MAMs in regulating mitochondrial quality control. This review will delve into the molecular mechanisms underlying the imbalance in mitochondrial quality control in AD and provide a comprehensive overview of the role of MAMs in regulating mitochondrial quality control.
Insights
Alzheimer's disease involves mitochondrial dysfunction, with mitochondrial-associated membranes (MAMs) crucial for quality control. This review explores MAMs' role in regulating mitochondrial quality, impacting Alzheimer's disease progression.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with significant public health implications.
- Mitochondrial-associated membranes (MAMs) are key interfaces for communication between mitochondria and the endoplasmic reticulum.
- MAMs are implicated in signal transduction and material transport, influencing AD pathogenesis.
Purpose of the Study:
- To elucidate the molecular mechanisms of impaired mitochondrial quality control in Alzheimer's disease.
- To provide a comprehensive overview of the role of MAMs in regulating mitochondrial quality control within the context of AD.
Main Methods:
- This is a review article, synthesizing existing research.
- Focuses on molecular mechanisms and regulatory roles.
Main Results:
- Dysregulation of mitochondrial quality control is a fundamental factor in AD development.
- Mitochondrial dysfunction and neurodegeneration are consequences of this dysregulation.
- MAMs play a pivotal role in regulating mitochondrial quality control.
Conclusions:
- MAMs are central to maintaining mitochondrial homeostasis.
- Understanding MAMs' function in quality control is critical for developing AD therapies.
- Targeting MAMs may offer a novel therapeutic strategy for Alzheimer's disease.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Mitochondria
Animal Mitochondrial Genetics
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...


